Drug Enforcement Administration – Federal Register Recent Federal Regulation Documents

Results 1 - 50 of 3,486
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Document Number: 2020-13336
Type: Notice
Date: 2020-06-22
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I
Document Number: 2020-12304
Type: Proposed Rule
Date: 2020-06-18
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)ethan-1-amine (commonly known as isotonitazene), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle isotonitazene.
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Document Number: 2020-13009
Type: Notice
Date: 2020-06-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Woodfield Distribution, LLC
Document Number: 2020-13008
Type: Notice
Date: 2020-06-17
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Document Number: 2020-12858
Type: Notice
Date: 2020-06-15
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Exempt Anabolic Steroid Products
Document Number: 2020-11318
Type: Rule
Date: 2020-06-15
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is designating two pharmaceutical preparations containing esterified estrogens and methyltestosterone as exempt anabolic steroid products under the Controlled Substances Act.
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Document Number: C1-2020-10601
Type: Notice
Date: 2020-06-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cardinal Health
Document Number: 2020-12625
Type: Notice
Date: 2020-06-11
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Honeoye Manufacturing
Document Number: 2020-12383
Type: Notice
Date: 2020-06-09
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to proposed regulations that, if finalized, would govern the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2020-12377
Type: Notice
Date: 2020-06-09
Agency: Drug Enforcement Administration, Department of Justice
Listing of Ethylone in Schedule I of Controlled Substances and Assignment of an Administration Controlled Substances Code Number
Document Number: 2020-10295
Type: Rule
Date: 2020-06-08
Agency: Drug Enforcement Administration, Department of Justice
This is a final rule issued by the Drug Enforcement Administration (DEA) establishing a specific listing and administration controlled substances code number for ethylone (also known as 1-(1,3- benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4-methylenedioxy-N- ethylcathinone; bk-MDEA; MDEC) in schedule I of the Controlled Substances Act (CSA).
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2020-12180
Type: Notice
Date: 2020-06-05
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Document Number: 2020-12177
Type: Notice
Date: 2020-06-05
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Nalas Engineering Services, Inc.
Document Number: 2020-12175
Type: Notice
Date: 2020-06-05
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2020-12086
Type: Notice
Date: 2020-06-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Bellwyck Clinical Services
Document Number: 2020-12082
Type: Notice
Date: 2020-06-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Akorn, Inc.
Document Number: 2020-12080
Type: Notice
Date: 2020-06-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Agilent Technologies
Document Number: 2020-11546
Type: Notice
Date: 2020-05-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Rhodes Technologies
Document Number: 2020-11393
Type: Notice
Date: 2020-05-28
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.
Document Number: 2020-11077
Type: Notice
Date: 2020-05-22
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Biopharmaceutical Research Company LLC
Document Number: 2020-10734
Type: Notice
Date: 2020-05-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Scientific Botanical Pharmaceutical, Inc.
Document Number: 2020-10625
Type: Notice
Date: 2020-05-18
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Document Number: 2020-10601
Type: Notice
Date: 2020-05-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Restek Corporation
Document Number: 2020-10465
Type: Notice
Date: 2020-05-15
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I
Document Number: 2020-09599
Type: Proposed Rule
Date: 2020-05-15
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing 1-(4- methoxyphenyl)-N-methylpropan-2-amine (para- methoxymethamphetamine, PMMA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle PMMA.
Schedules of Controlled Substances: Placement of Zipeprol in Schedule I
Document Number: 2020-09592
Type: Proposed Rule
Date: 2020-05-14
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes placing the substance zipeprol (Chemical name: 1-methoxy-3-[4-(2-methoxy-2- phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle zipeprol.
Isaac J. Hearne, M.D.; Decision and Order
Document Number: 2020-09722
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Michael Thomas Watkins, M.D.; Decision and Order
Document Number: 2020-09721
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: AndersonBrecon Inc. dba PCI of Illinois
Document Number: 2020-09707
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Document Number: 2020-09706
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Novitium Pharma LLC
Document Number: 2020-09705
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Alcami Wisconsin Corporation
Document Number: 2020-09702
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Document Number: 2020-09701
Type: Notice
Date: 2020-05-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Patheon API Manufacturing, Inc.
Document Number: 2020-09556
Type: Notice
Date: 2020-05-05
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Document Number: 2020-09555
Type: Notice
Date: 2020-05-05
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Absolute Standards, Inc.
Document Number: 2020-09553
Type: Notice
Date: 2020-05-05
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Alcami Carolinas Corporation
Document Number: 2020-09552
Type: Notice
Date: 2020-05-05
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Unither Manufacturing LLC
Document Number: 2020-09514
Type: Notice
Date: 2020-05-05
Agency: Drug Enforcement Administration, Department of Justice
Kansky J. Delisma, M.D.; Decision and Order
Document Number: 2020-09057
Type: Notice
Date: 2020-04-29
Agency: Drug Enforcement Administration, Department of Justice
Malathy Sundaram, M.D.; Decision and Order
Document Number: 2020-08885
Type: Notice
Date: 2020-04-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Andersonbrecon, Inc, DBA PCI of Illinois
Document Number: 2020-08669
Type: Notice
Date: 2020-04-24
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Sigma Aldrich Co., LLC
Document Number: 2020-08354
Type: Notice
Date: 2020-04-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals
Document Number: 2020-08352
Type: Notice
Date: 2020-04-21
Agency: Drug Enforcement Administration, Department of Justice
Electronic Prescriptions for Controlled Substances
Document Number: 2020-07085
Type: Rule
Date: 2020-04-21
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) published an interim final rule in the Federal Register on March 31, 2010, which provides practitioners with the option of writing prescriptions for controlled substances electronically. Since publishing the interim final rule, DEA has received questions and requests for clarification on various issues concerning the implementation and technical requirements for the electronic prescribing of controlled substances. DEA is therefore reopening the March 31, 2010, interim final rule to solicit comments from the public on specific issues outlined below regarding the electronic prescribing of controlled substances in anticipation of subsequently publishing a final rule on these topics.
Importer of Controlled Substances Application: Lipomed
Document Number: 2020-08341
Type: Notice
Date: 2020-04-20
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Groff NA Hemplex LLC
Document Number: 2020-08334
Type: Notice
Date: 2020-04-20
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to proposed regulations that, if finalized, would govern the program of growing marihuana for scientific and medical research under DEA registration.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Absolute Standards, Inc.
Document Number: 2020-08332
Type: Notice
Date: 2020-04-20
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to proposed regulations that, if finalized, would govern the program of growing marihuana for scientific and medical research under DEA registration.
Bulk Manufacturer of Controlled Substances Application: AMRI Rensselaer, Inc.
Document Number: 2020-08330
Type: Notice
Date: 2020-04-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Document Number: 2020-08328
Type: Notice
Date: 2020-04-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: AMRI Rensselaer, Inc.
Document Number: 2020-08271
Type: Notice
Date: 2020-04-20
Agency: Drug Enforcement Administration, Department of Justice